SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-012062
Filing Date
2021-05-13
Accepted
2021-05-13 16:13:37
Documents
19
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210415_8k.htm 8-K 27710
2 EXHIBIT 99.1 ex_241430.htm EX-99.1 126084
3 EXHIBIT 99.2 ex_241431.htm EX-99.2 9402
4 a1.jpg GRAPHIC 11754
5 slide1.jpg GRAPHIC 49048
6 slide2.jpg GRAPHIC 255383
7 slide3.jpg GRAPHIC 46475
8 slide4.jpg GRAPHIC 202182
9 slide5.jpg GRAPHIC 173718
10 slide6.jpg GRAPHIC 178303
11 slide7.jpg GRAPHIC 194650
12 slide8.jpg GRAPHIC 172024
13 slide9.jpg GRAPHIC 134592
14 slide10.jpg GRAPHIC 23129
15 slide11.jpg GRAPHIC 144742
16 slide12.jpg GRAPHIC 153894
17 slide13.jpg GRAPHIC 128138
18 slide14.jpg GRAPHIC 145930
19 slide15.jpg GRAPHIC 43976
  Complete submission text file 0001437749-21-012062.txt   2994898
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 21919780
SIC: 2834 Pharmaceutical Preparations